Vertex's stock rallies on experimental pain pill trial resul

Vertex wants to interrupt pain signals before they reach the brain, and because its non-opioid drug would bypass the central nervous system, it would provide pain relief without the risk of addiction.

Related Keywords

South San Francisco , California , United States , Boston , Massachusetts , Switzerland , Cambridge , Cambridgeshire , United Kingdom , San Diego , Swiss , American , Aurora Biosciences , David Altshuler , Marks Wallace , David Risinger , Vincent Alban , Brian Abrahams , Purdue Pharma , University Of California , Regeneron Pharmaceuticals , Drug Administration , Novartis , Genentech , Boston Globe , National Academy Of Medicine , Broad Institute , Cambridge Based Biogen , Leerink Partners , Vincent Alban For The Boston , New England Journal , National Academy , ,